Translucence Biosystems

Translucence Biosystems is a private, early-revenue stage company founded in 2019, based in Irvine, California. It operates at the intersection of medical devices, neuroscience tools, and services, providing an end-to-end platform to transform traditional 2D histology into high-resolution 3D tissue analysis. The company's core technology includes its Universal and application-specific Tissue Clearing Kits, the Mesoscale Imaging System™ for optimized light sheet microscopy, and proprietary software for stitching and quantifying large 3D datasets. Its primary business model combines product sales (kits, hardware) with fee-for-service analytical work, targeting academic, biopharma, and clinical researchers in neurodegenerative disease, neuroinflammation, and beyond.

Integrated platform for 3D tissue analysis comprising proprietary tissue clearing chemistry kits (e.g., Universal, Neuronal Activity), the Mesoscale Imaging System™ (hardware optimization for ZEISS light sheet microscopes), and AI-powered software for 3D reconstruction and quantification.

Operates in a competitive market for 3D tissue clearing and imaging, competing against other specialized startups (e.g., LifeCanvas Technologies, Miltenyi Biotec's Miltenyi Imaging) and reagent divisions of large companies. Its differentiation lies in its integrated hardware-software-chemistry platform and full-service pipeline, but it must contend with established academic protocols and open-source methods.